Guido Bisping

1.2k total citations
28 papers, 845 citations indexed

About

Guido Bisping is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Guido Bisping has authored 28 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Guido Bisping's work include Multiple Myeloma Research and Treatments (11 papers), Immune Cell Function and Interaction (4 papers) and Protein Degradation and Inhibitors (4 papers). Guido Bisping is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Immune Cell Function and Interaction (4 papers) and Protein Degradation and Inhibitors (4 papers). Guido Bisping collaborates with scholars based in Germany, Austria and Greece. Guido Bisping's co-authors include Wolfgang E. Berdel, Joachim Kienast, Martin Kropff, Andreas H. Groll, Gabriele Koehler, Athanasios Tragiannidis, Nicola Lang, Rolf M. Mesters, M. Hentrich and Achim Heinecke and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Guido Bisping

28 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Bisping Germany 17 458 436 302 106 106 28 845
Sonia Cellot Canada 14 276 0.6× 410 0.9× 184 0.6× 88 0.8× 125 1.2× 44 787
James K. Mangan United States 18 514 1.1× 345 0.8× 347 1.1× 108 1.0× 194 1.8× 64 1.1k
Ivana von Metzler Germany 17 350 0.8× 594 1.4× 467 1.5× 70 0.7× 150 1.4× 31 951
David Jayabalan United States 16 540 1.2× 562 1.3× 396 1.3× 169 1.6× 149 1.4× 71 992
Xiujin Ye China 16 526 1.1× 326 0.7× 253 0.8× 70 0.7× 236 2.2× 94 984
JL Harousseau France 19 895 2.0× 594 1.4× 675 2.2× 77 0.7× 142 1.3× 24 1.4k
Alexandros Spyridonidis Greece 20 594 1.3× 281 0.6× 272 0.9× 63 0.6× 234 2.2× 75 1.1k
C. Michel Zwaan Netherlands 18 554 1.2× 450 1.0× 449 1.5× 54 0.5× 86 0.8× 34 1.2k
Ravindran Ankathil Malaysia 22 225 0.5× 649 1.5× 318 1.1× 107 1.0× 92 0.9× 99 1.3k
Ugo Consoli Italy 17 257 0.6× 367 0.8× 395 1.3× 42 0.4× 239 2.3× 36 863

Countries citing papers authored by Guido Bisping

Since Specialization
Citations

This map shows the geographic impact of Guido Bisping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Bisping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Bisping more than expected).

Fields of papers citing papers by Guido Bisping

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Bisping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Bisping. The network helps show where Guido Bisping may publish in the future.

Co-authorship network of co-authors of Guido Bisping

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Bisping. A scholar is included among the top collaborators of Guido Bisping based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Bisping. Guido Bisping is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kropff, Martin, Martin Vogel, Guido Bisping, et al.. (2017). Bortezomib and low-dose dexamethasone with or without continuous low-dose oral cyclophosphamide for primary refractory or relapsed multiple myeloma: a randomized phase III study. Annals of Hematology. 96(11). 1857–1866. 14 indexed citations
2.
3.
Matzdorff, Axel, Hanno Riess, Frauke Bergmann, et al.. (2015). Cancer Screening in Patients with Idiopathic Venous Thromboembolism - a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis. Oncology Research and Treatment. 38(9). 454–458. 3 indexed citations
4.
Rijcken, Emile, Soeren Torge Mees, Guido Bisping, et al.. (2014). Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): A retrospective cohort study on longtime response predicting factors based on consensus criteria. International Journal of Surgery. 12(12). 1428–1433. 23 indexed citations
5.
Tragiannidis, Athanasios, Guido Bisping, Gabriele Koehler, & Andreas H. Groll. (2009). Minireview:Malasseziainfections in immunocompromised patients. Mycoses. 53(3). 187–195. 76 indexed citations
6.
Landmeier, Silke, Bianca Altvater, Sibylle Pscherer, et al.. (2009). Activated Human γδ T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes. Journal of Immunotherapy. 32(3). 310–321. 28 indexed citations
7.
Meister, Tobias, Guido Bisping, Matthias Stelljes, et al.. (2008). Intestinal graft-versus-host-disease staging by video capsule endoscopy. Endoscopy. 40(S 02). E144–E144. 4 indexed citations
8.
Stelljes, Matthias, Jörn C. Albring, Hans‐Gerd Pauels, et al.. (2007). Differential Requirement for a Cellular Type-1 Immune Response in Tumor-Associated Versus Alloantigen-Targeted GvT Effects. Transplantation. 83(3). 314–322. 2 indexed citations
9.
Kropff, Martin, Guido Bisping, Peter Liebisch, et al.. (2007). Bortezomib in combination with intermediate‐dose dexamethasone and continuous low‐dose oral cyclophosphamide for relapsed multiple myeloma. British Journal of Haematology. 138(3). 330–337. 124 indexed citations
10.
Kropff, Martin, et al.. (2006). Proteasome inhibition in multiple myeloma. European Journal of Cancer. 42(11). 1623–1639. 23 indexed citations
11.
12.
Kropff, Martin, et al.. (2005). Bortezomib in combination with dexamethasone for relapsed multiple myeloma. Leukemia Research. 29(5). 587–590. 43 indexed citations
13.
14.
15.
Kropff, Martin, Nicola Lang, Guido Bisping, et al.. (2003). Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma. British Journal of Haematology. 122(4). 607–616. 96 indexed citations
16.
Bisping, Guido, Regine Leo, Berno Dankbar, et al.. (2003). Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. Blood. 101(7). 2775–2783. 101 indexed citations
17.
Geiser, Edward A., Horst Wedekind, Guido Bisping, et al.. (2002). Differential diagnosis of “dysphagia” in an elderly woman. Clinical Cardiology. 25(3). 132–132. 1 indexed citations
18.
Domagk, Dirk, Guido Bisping, Christopher Poremba, et al.. (2001). Common Bile Duct Obstruction Due to Candidiasis. Scandinavian Journal of Gastroenterology. 36(4). 444–446. 14 indexed citations
19.
20.
Assert, Roland, Ralf Kötter, Guido Bisping, et al.. (1999). Anti‐proliferative activity of protein kinase C in apical compartments of human colonic crypts: Evidence for a less activated protein kinase C in small adenomas. International Journal of Cancer. 80(1). 47–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Cellot Breakdown of academic impact, for papers by James K. Mangan Breakdown of academic impact, for papers by Ivana von Metzler Breakdown of academic impact, for papers by David Jayabalan Breakdown of academic impact, for papers by Xiujin Ye Breakdown of academic impact, for papers by JL Harousseau Breakdown of academic impact, for papers by Alexandros Spyridonidis Breakdown of academic impact, for papers by C. Michel Zwaan Breakdown of academic impact, for papers by Ravindran Ankathil Breakdown of academic impact, for papers by Ugo Consoli
Rankless by CCL
2026